Skip to content

Clinical characteristics of dyslipidemia and intervention effect of Xuanfeijiangzhi Formula

Clinical characteristics of dyslipidemia and intervention effect of Xuanfeijiangzhi Formula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000178
Enrollment
Unknown
Registered
2025-01-25
Start date
2025-02-03
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal lipid metabolism

Interventions

Control group:Non pharmacological treatment measures+atorvastatin+placebo treatment
Experimental group:Non pharmacological treatment measures+pharmacological treatment+Xuanfei lipid-lowering formula treatment

Sponsors

Shanghai Jiangong Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for dyslipidemia; 2. Meets the diagnostic criteria of traditional Chinese medicine: The diagnostic criteria of traditional Chinese medicine refer to the differentiation of syndromes: the treatment group is classified based on traditional Chinese medicine differentiation using the 2017 Expert Consensus on the Integration of Traditional Chinese and Western Medicine for Blood Lipid Abnormalities. Complies with the syndrome differentiation of spleen and lung qi deficiency. Spleen lung qi deficiency refers to the weak symptoms caused by spleen and lung qi deficiency mainly manifested as spleen dysfunction and lung dysfunction. Main symptoms: loss of appetite bloating and loose stools persistent cough shortness of breath and wheezing low voice and lazy speech fatigue and shortness of breath. Secondary symptoms: Clear and sparse phlegm or floating limb swelling in the perineum with white and lifeless face. Tongue veins: The tongue texture is light the coating is white and smooth and the veins are thin and weak. 3. Aged 18-80 years old; 4. Patients with elevated serum lipids (cholesterol triglyceride low-density lipoprotein lipoprotein a); 5. Volunteer to participate and cooperate with the investigators and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Persons with mental disorders; 2. Pregnant or lactating women; 3. Patients allergic to the study drugs; 4. Be more than 80 years old or less than 18 years old; 5. Patients who participated in other clinical trials within the past month; 6. Refusal to sign informed consent. 7. Severe liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
Biochemical blood lipid indicators;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Points;liver function;renal function;creatine kinase;

Countries

China

Contacts

Public ContactCui Linghui

Shanghai Jiangong Hospital

lcy494983001qq@126.com17685428550

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026